Demira

Lilly, after making $1B bet, posts 'compelling' late-phase data on Dupixent rival
Fierce Biotech
Mon, 03/28/22 - 10:20 am
Eli Lilly
lebrikizumab
Demira
Sanofi
Regeneron
Dupixent
atopic dermatitis
Dermira vets license back candidates from Eli Lilly to launch their own upstart
Endpoints
Thu, 01/7/21 - 11:35 am
Demira
Eli Lilly
Evommune
Dermira secures FDA fast track status for lebrikizumab in atopic dermatitis
Pharmaceutical Business Review
Wed, 12/11/19 - 10:33 am
Demira
atopic dermatitis
FDA
fast track
Why Dermira Stock Jumped Again Today
Motley Fool
Tue, 03/19/19 - 08:19 pm
Demira
lebrikizumab
atopic dermatitis
Dermira Commits $135M for Global Rights to Roche Eczema Drug
Xconomy
Tue, 08/8/17 - 11:15 pm
Demira
Roche
eczema
lebrikizumab